Table: Fuji Pharmaceutical -2022/23 parent results

Fuji Pharma

09/11/2023 08:00

Nov 9 (Reuters)- 
          Fuji Pharmaceutical  Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Sep 30, 2023    Sep 30, 2022   Sep 30, 2024     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           37.42           32.55          45.02        21.71    
               (+15.0 pct)     (+2.2 pct)     (+20.3 pct)  (+20.4 pct) 
  Revenues                                        4.54         1.84    
                                              (+31.2 pct)  (+36.0 pct) 
  Operating        3.46            3.45                                
               (+0.1 pct)      (+2.4 pct)                              
  Recurring        4.07            3.40           5.23         2.60    
               (+19.9 pct)     (+2.3 pct)     (+28.4 pct)  (+24.7 pct) 
  Net              3.12            2.48           3.83         1.86    
               (+25.7 pct)     (-2.9 pct)     (+22.9 pct)  (+24.9 pct) 
  EPS          128.27 yen      102.10 yen     157.60 yen    76.70 yen  
  Ann Div       37.00 yen       35.00 yen      42.50 yen               
  -Q2 Div       17.00 yen       15.00 yen      20.00 yen               
  -Q4 Div       20.00 yen       20.00 yen      22.50 yen               
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T